Search

Learn more about how a clinical trial at MSK revealed important connections between the foods we eat and our cancer risk.

… Monday, December 8, 2025 If you or a loved one is facing cancer, you may wish you could regain some sense of control when so much feels beyond your power. You may wonder what you can or should eat. Comfort food? Healthy food? How much does it matter? The effort at Memorial Sloan Kettering Cancer Center

There is a significant threat to pediatric cancer research stemming from COVID-19's impact on philanthropy. That message is shared by MSK’s Chair of the Department of Pediatrics, Andrew Kung, MD, PhD, in a recent op-ed published in U.S. News & World Report.

… Thursday, October 1, 2020 There is a significant threat to pediatric cancer research stemming from COVID-19’s impact on philanthropy. That message is shared by MSK’s Chair of the Department of Pediatrics, Andrew Kung, MD, PhD , in a recent op-ed published in U.S. News & World Report . Dr. Kung points

To mark National Colorectal Awareness Month this March, MSK stressed the importance of resuming vital screenings for colorectal cancer amid the COVID-19 pandemic.

… Wednesday, March 3, 2021 To mark National Colorectal Awareness Month this March, Memorial Sloan Kettering Cancer Center (MSK) today stressed the importance of resuming vital screenings for colorectal cancer .  The American Cancer Society (ACS) has recommended colorectal cancer screenings begin at age

One size does not fit all when it comes to treating renal cell carcinoma.

… Tuesday, January 15, 2019 Summary Scientists at Memorial Sloan Kettering have identified factors in a tumor’s environment that predict how well it will respond to certain cancer therapies. If cancer is like a weed that sprouts from a seed, then the tumor microenvironment is like the soil that nurtures

Cancer screenings are essential. MSK’s Physician-In-Chief and Chief Medical Officer, Lisa DeAngelis, MD, shared why cancer care screenings are critical during an interview with PBS Metrofocus.

… Friday, August 14, 2020 It’s time to go back. Cancer care is essential care and screenings and treatments can’t wait. That was the message that MSK’s Physician-In-Chief and Chief Medical Officer, Lisa DeAngelis, MD, shared during a recent interview with  PBS Metrofocus .  When COVD-19 first hit the tri-state

The newest edition of the thyroid cancer staging system has increased the age at diagnosis as a prognostic factor by a decade.

… Friday, March 1, 2019 The newest edition of the thyroid cancer staging system has increased the age at diagnosis as a prognostic factor by a decade. To understand the impact of this, and other recent changes, we staged patients using our extensive, prospectively collected database at Memorial Sloan Kettering

MSK physicians and scientists are involved in notable research to be presented at the meeting and are available to comment on a variety of topics within leukemia, lymphoma, and multiple myeloma.

… Friday, December 4, 2020 Thousands of oncology experts from around the world will tune in December 5-8, 2020 for The American Society of Hematology’s (ASH) Annual Meeting and Exposition . For more than 60 years, the (ASH) Annual Meeting and Exposition has been the world’s most comprehensive hematology

MSK investigators report a new tool that may help them determine the origin of some metastatic tumors, potentially leading to better targeted treatments.

… Thursday, November 14, 2019 Summary Despite many advances in diagnostic technologies, the original site of some cancers will never be found. A new tool may help. Experts estimate that between 2 and 5% of all cancers are classified as cancer of unknown primary (CUP) , also called occult primary cancer

The BRCA Founder Outreach study was recently launched to look at how patients undergo genetic screenings for cancer.

… Wednesday, April 25, 2018 Summary A new study led by MSK and three other cancer centers is looking at different aspects of testing for cancer genes. In March 2018, the US Food and Drug Administration approved an at-home, mail-in kit that tests for some of the inherited mutations in the genes BRCA1 and

Global regulatory harmonization of clinical trials provides significant opportunity to accelerate access to cancer treatments to benefit all of humanity. This was the theme of the fifth annual MSK-CTONG Symposium, hosted online for a global audience of 20,000 from Guangzhou, China and New York on December 2, 2022.

… Wednesday, December 28, 2022 Global regulatory harmonization of clinical trials provides significant opportunity to accelerate access to cancer treatments to benefit all of humanity. This was the theme of the fifth annual MSK-CTONG Symposium, hosted online for a global audience of 20,000 from Guangzhou